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USING IMMUNOASSAY PROCEDURES (COX
& Goken, 1976) nanogram levels of DNA
have been detected in sera of animals
and man. On the other hand, less sensitive
methods are needed to detect the micro-
gram levels of serum DNA in humans
with lupus erythromatosus, rheumatoid
arthritis or leukaemia (Koffler et al.,
1973). When the nucleic acids from the
ascites fluid from white Porton mice,
inoculated 7 days earlier with 4 x 107
Krebs 2 tumour cells, were determined, a
high concentration was also encountered
(70-150 pLg/ml; DNA/RNA=0 6-0.8).
When isolated by phenol extraction and
analysed by electrophoresis on 8-75%
polyacrylamide gels, there is a conspicuous
DNA species mnigrating just short of
marker E. coli 58 RNA. Such a species
has also been recently detected in the
extracellular ascitic fluid of Ehrlich and
NK/Ly tumours of mice, hepatoma 22a,
Zajdela hepatoma and ovarian ascites
tumours of rats (Beloskhvostov et al.,
1976) as well as in ascites fluid in human
ovarian tumours (Zelenkova et al. 1980).
This is not the only nucleic acid species
present. Analysis on 1.5% agarose gels
revealed larger species, notably a band
migrating with a mobility similar to that
of mouse mitochondria DNA. Analyses
of Krebs 2 extracellular ascitic fluid
at various stages of tumour growth
indicate that these DNA species are
readily visible only at later growth
stages, suggesting accumulation in the
extracellular fluid (the level at 4 days
is about 10% that at 7 days). The extra-
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cellular RNA moieties seem to be spread
heterogeneously throughout the gels.
In view of this high level of nucleic
acids detectable in ascites fluid, the
question arises concerning their origin
and possible biological significance. We
do not find these high levels in the blood
from normal mice or indeed from mice
carrying the tumour.
From preliminary isotope labelling and
growth studies carried out in vivo it
seems that considerable cell loss occurs
during the development of the Krebs 2
tumour. This is similar to the situation
during the development of the Ehrlich
ascites tumour, where Lala & Patt (1966)
found that, although the fraction of
cells lost per unit time was constant,
the rate of cell loss as a proportion of
the rate of cell production rose progres-
sively from 18% on Day 1 to 70o/% on
Day 7). Thus tumour-cell loss is a likely
cause ofthe high levels of DNA and RNA
fragments in ascitic fluid, the survival
of which therein may well be a function
oftheir protection by nucleic-acid-binding
proteins. Indeed addition of very high
levels of exogenous DNase to ascites
fluid (1-2 mg/ml) is required to elicit
any further degredation of the DNA in
these putative complexes, and metri-
zamide-gradient analyses indicate a con-
siderable association of the nucleic acid
fragments with protein. The question
whether nucleic acid fragments might
influence tumour growth was prompted
by early cell-culture studies of Ely &
Gray (1960), which indicated that theR. H. BURDON, G. M. SILLAR AND E. ALLEN
addition of DNA fragments to the culture
medium improved in vitro growth of
Krebs 2 cells. The foetal calf serum
used in the culture did contain some
DNase activity, but this was low enough
(5 [kg DNA rendered acid soluble/h/ml
serum) for exogenous DNA to persist
some time in the culture medium. Exo-
genous DNA may also bind proteins in
the serum (Cox & Cocken, 1976). From
Fig. la it can be seen that the addition
of 300 tLg/ml DNA (calf thymus) had a
beneficial effect on the growth of tumour
cells from 2-day tumours (30 Hg/ml DNA
not produce significant stimulation). This
stimulation could be abolished by prior
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FIG. I.Effect ofexogenous nucle_c acids an__
nucleases on growth- of Krebs 2 tumour
in vitro. (a) Tumour from mice inoculated
2 days previously with 4 x 107 tumour cells
in Eagle's M1EM-10% FCS t'ibco, Europe)
and 3ml aliquots dispensed into 60 x
15 mm Falcon plastic dishes for incubation
in 5% CE2/air at 37oC. At various interisals
direct counts were made ofmorphologically
recognizable Krebs 2 tumour cells. ( )
dishes wVitli no addlitions; (A) disbes
with 900 )ug added calf tliymus DNA.
(b) 2-day tumour was remoed from mice
andmixeay witol an equal volume of PBS
or PBS containing eitEoer F mg/ml DNase
or 2 mg/ml RNase A and inctibated for
5 min at 37°C. After dilution with Eagle's
MEaI-10% FCS 3ml were aliquots dis-
pensed into distic isrin (a). At various
intervals tumour cell number vas counted.
(r) untreated cells; (ma) DNase I treated
cells (c) RNase A treated cells. (In bot0
groups bars indicate +s.d. Trypan-blue
staining indicated not more than 4I
"dead" cells at all stages).
treatment of the added DNA with DNase
1, and reduced by prior heat denaturation
of the DNA. Poly(A), tRNA (E. coli) and
ribosomal RNA (E. coli) were without
effect. This may in part be because foetal
calf serum is capable of degrading 95%
of the added naked RNA in 30 min at
37°C under the culture conditions used.
In these experiments the total tumour
was simply withdrawn from the host,
diluted directly with grown medium and
incubated in vitro, No attempt was made
to separate tumour cells from non-
tumour cells, or from ascites fluid. Exanm-
ination of the tumour microscopically
indicated that, whilst 80% of the cells
in the peritoneal ascites fluid were tumour
cells after both 3 and 7 days of growth,
the balance were non-tumour cells, e.g.
lymphocytes and macrophages. (See also
Klein & Revesz, 1953.)
Since binding of exogenous DNA to
the surface of Ehrlich ascites cells has
been reported (Schell, 1968) it was
important to ascertain whether bindng
of exogenous DNA to Krebs 2 cells also
took place. 900 tg Krebs 2 cell [3H]DNA
was added to dishes containing 2-day
tumour diluted in 3 ml foetal calf serum/
MEM (corresponding to 8x 105 tumour
cells). After 6 h at 37°C the cells were
removed and analysed for bound 3H-DNA
as described by Schell (1968). 0.30o of
the added DNA bound to the cell surface.
Cell-surface-associated DNA on tumori-
genic cells has also been reported using
anti-tumour platinum-pyrimidine com-
plexes and electron microscopy (Aggarwal
el al. 1975).
We then investigated the ability of
cells from 2-day tumours to grow in
culture after pretreatment with the high
levels ofelectrophoretically purified DNase
I (1 mg/ml) sufficient to digest the DNA
of most of the nucleoprotein complexes
in the extracellular ascites fluid. This
treatment depressed the growth oftumour
cells (Fig. lb). Pretreatment with high
levels of RNase A was also effective.
It could be however that such unnaturally
high levels of nucleases might simply
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FIG. 2.-Effect on exogenous DNA on the i.p.
growth of Krebs 2 ascites tumours. Groups
of 4-5 white Porton mice (' 40 g) inocu-
lated with Krebs 2 tumour cells in PBS. The
groups were then collectively weighed at
various times. The relative body weight is
the ratio of the collective group weight
at a given time to weight of that group
(Day 0). [If any animal within a group
dies the analysis of that particular group
is terminated]. Arrows indicate i.p.
injections of 100 jig DNA on 0-2 ml PBS
in some groups. (a) All mice inoculated with
4 x 107 tumour cells (0) control group
(PBS only) (A) group receiving calfthymus
DNA; (A) group receiving E. coli DNA.
(b) All mice inoculated with 4 x 104 tumour
cells; (0) control group; (A) group receiv-
ing calf thymus DNA as indicated by the
arrows.
be toxic to mammalian cells in general.
L-929 strain of mouse fibroblasts was
allowed to grow for 3 days in medium
containing added DNase (1 mg/ml) or
RNase (2 mg/ml) or DNA (calf thymus,
300 ,ug/ml. None of these additions had
significant effect on L cells. The nucleic
acids (or nucleoproteins) might simply
protect the actual tumour cells from the
destructive potential of some other com-
ponent of the tumour, for example
natural or induced cytotoxic non-tumour
cells (Heberman & Holden, 1978) or
constituents ofthe ascites fluid.
In view of these in vitro data, the
effects of exogenous nucleic acids and
nucleases on the i.p. growth ofthe Krebs 2
tumour were assessed, the extent of
tumour growth in vivo being measured by
relative weight gain (Patt & Blackford,
1954).
If the usual inoculation of tumour,
containing 4 x 107 tumour cells, was carried
out, but 1, 2, 3 and 4 days thereafter,
100lg portions of DNA, in 0-2 ml PBS,
were injected i.p. (controls receiving
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FIG. 3.-Effect of nucleases at various stages
on the i.p. development of Krebs 2 ascites
tumours from smallinocula. Mice ofvarious
groups were each inoculated with 4 x 104
tumour cells and collectively weighed at
intervals (as for Fig. 2). (a) The mice in one
group (U) received i.p. injections of 2 mg
RNase A in 0-2 ml PBS immediately after
tumour-cell inoculation and then as indi-
cated by the arrows. Control group received
PBS alone (0). (b) The mice in certain
groups received i.p. injections of 2 mg
RNase A (-) orDNaseI(D)in 0.2 ml PBS
on days indicated by arrows. Control group
group receiving PBS alone (0). The num-
bers on right indicate the numbers of mice
with obvious tumours at postmortem ex-
amination as a fraction of the number of
mice in the group.
only PBS), the development ofthe tumour
was enhanced (Fig. 2a). DNA from mouse
or calf thymus was equally effective
but E. coli DNA was less so. This stimu-
latory effect of DNA could be reproduced
when the tumour inoculum was reduced
to only 4 x 104 tumour cells per mouse
(see Fig. 2b), but RNA administration
had a varied and less pronounced stimu-
latory effect (N.B., naked RNA is more
rapidly degraded by ascites fluid than is
naked double-stranded DNA).
When aliquots of whole tumour were
removed from mice and pretreated with
DNase (1 mg/ml) or RNase (2 mg/ml) at
37°C for 3 min before inoculation into
fresh mice (4 x 107 tumour cells per mouse)
there was subsequent gain in body weight
but only half the normal. Using smaller
tumour inocula, (4 x 104 tumour cells)
followed immediately, and also on days
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1, 2, 4 and 7 by RNase injection, there was
no tumour growth over the next 21 days
(Fig. 3a). If the inoculation with 4 x 104
tumour cells is followed by successive
administration of RNase (or DNase) after
a delay of 24 h, tumour development
(Fig. 3b) is very significantly retarded
(more effectively by RNase than by
DNase). However, if tumour development
after small inocula (4 x 104 tumour cells)
is allowed to proceed for 7 days before
nuclease treatment, tumour growth is
only half.
In these in vivo experiments, RNase
was always slightly more effective than
DNase. When these nucleases were added
directly to aliquots of ascites fluid in vitro
and then assayed for activity various
times after incubation at 37°C, the activity
of RNase remained at its original value,
whilst that of DNase always declined
to about half its original value after 3 h.
Thus DNase is labile in ascites fluid at
37°C, which might explain its lower
activity when administered to tumour-
bearing mice.
It is difficult at this stage to be precise
regarding the mechanism of these modu-
latory effects on Krebs 2 tumour growth,
as the reasons for cell loss during growth
are not precisely known. One possibility
is the random loss of cells termed "apop-
tosis" (Kerr et at., 1972). This can occur
either because it is an intrinsic property
oftumour cells or because offactors in the
tumour environment. Whether it can be
inhibited by extracellular nucleic acid
or nucleoptotein moieties is not known.
It is also likely that some form of
cell-mediated toxicity ("natural" or "in-
duced") may be responsible for cell loss.
Cytotoxic effector cells are present in
both normal and immunodeficient mice,
and can lyse a wide range of cells of
tumour origin (Heberman & Holden,1978).
Such cells, which are present in significant
level without prior priming, and have no
immunological memory, may provide an
early defence against implanted Krebs 2
cells. As already stressed, non-tumour
cells are found amongst the tumour cells
at all stages of growth, and we made
no attempt to remove them. In later
stages some of these non-tumour cells
may be involved in induced cell-mediated
cytotoxicity. Despite the ease with which
the Krebs 2 tumour can be grown in
white Porton mice it must still be con-
sidered an allograft. Whether, after trans-
plantation, cellular nucleic acid or nucleo-
protein fragments released from lysed cells
can become associated with intact tumour
or lymphocyte cell-surface components
to "block" nonspecifically various cyto-
toxic agents deserves consideration. Indeed
such a phenomenon might have implica-
tions for transplantation in general.
Belokhvostov et al. (1979) have some data
to support the possibility that nucleic
acid could have a suppressive function.
The in vitro and in vivo effects of high
levels of nuclease may simply reflect the
ability to relieve this nonspecific "block-
ing" effect by enzymic digestion. Un-
fortunately, this is insufficient to halt
tumourdevelopment invivoif carried out a
day or more after tumour implantation.
However, prolonged DNase treatment
has been successfully used to limit the
course of lymphatic leukaemia in AKR
mice (Salganik et al., 1967). On the other
hand it should be pointed out that it
could simply be that lymphoblasts are
more sensitive to the nuclease than are
normal cells. This of course may also
be true for Krebs 2 cells, but at least
our experiments indicate that it is not
the case for mouse fibroblasts (L cells).
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